Head-to-head comparison
CoreAge Rx vs Invyncible
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
$99/mo (12-month prepay) sema · $149/mo (12-month prepay) tirz · Verified August 2026
Marked down on: The advertised $99/$149 per month is a 12-month plan paid in full ($1,188 / $1,788 up front); no month-to-month price is published
Desk Score
Invyncible is a Florida telehealth platform pricing every GLP-1 dose program in the open, with all six of its compounding pharmacies named and patient-selectable.
From $149/mo (lowest dose rung) sema · From $180/mo (lowest dose rung) tirz · Verified August 2026
Marked down on: The entry price buys the smallest vial: the same plain semaglutide program runs $262.50 at 5 mg and $350 at 10 mg, which the FAQ confirms
CoreAge Rx takes this head-to-head with the higher Desk Score, 94/100 (A) against 73/100 (C) for Invyncible. Invyncible still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
CoreAge Rx
94/100
A
Invyncible
73/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | CoreAge Rx | Invyncible |
|---|---|---|
| Semaglutide | $99/mo12-month prepay$99/mo only as a 12-month plan paid in full ($1,188 in one charge); the lander says "starting at, based on a 12-month plan paid in full"; no month-to-month price is published; same price at every dose; compounded injectable | From $149/molowest dose rung$149/mo (0.45 mg dose, compounded with glycine + B12) |
| Tirzepatide | $149/mo12-month prepay$149/mo only as a 12-month plan paid in full ($1,788 in one charge); no month-to-month price is published; same price at every dose; compounded injectable | From $180/molowest dose rung$180/mo (2.5 mg weekly, 4-week program, compounded) |
| Coverage | All 50 states | 46 states plus DC |
| Brand-name | Compounded only | Yes |
| Oral option | Injectable only | Yes |
| Best for | Anyone who can prepay a year and wants one dose-independent price with full nationwide reach. | An open price list and a named, patient-selectable compounding pharmacy rather than an unnamed network. |
| Desk Score | 94/100A | 73/100C |
The verdict
Desk pick — CoreAge RxCoreAge Rx takes this head-to-head with the higher Desk Score, 94/100 (A) against 73/100 (C) for Invyncible. Invyncible still holds its ground where its strengths line up with yours.
Choose CoreAge Rx if…
Anyone who can prepay a year and wants one dose-independent price with full nationwide reach.
$99/mo (12-month prepay) sema · $149/mo (12-month prepay) tirz · All 50 states
Choose Invyncible if…
An open price list and a named, patient-selectable compounding pharmacy rather than an unnamed network.
From $149/mo (lowest dose rung) sema · From $180/mo (lowest dose rung) tirz · 46 states plus DC
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: CoreAge Rx · Invyncible.
More head-to-heads
- CoreAge Rx vs Strut Health
- Invyncible vs Ondra Health
- CoreAge Rx vs Ondra Health
- Invyncible vs Sesame Care
- CoreAge Rx vs Sesame Care
- Invyncible vs Vaylen
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.